**Patient Discharge Summary**

**Patient Information:**

* Name: Jane Doe
* Date of Birth: February 12, 1980
* Admission Date: March 10, 2023
* Discharge Date: March 25, 2023

**Admission and Diagnostic Workup:**

Jane Doe, a 43-year-old female, was admitted to the endocrinology unit on March 10, 2023, with complaints of fatigue, weight gain, and cold intolerance. Her medical history included hypertension, hyperlipidemia, and a family history of thyroid disease. On physical examination, she had a normal body mass index (BMI) but appeared pale and lethargic. Laboratory tests revealed an elevated serum thyroid-stimulating hormone (TSH) level of 25.6 mU/L (normal range: 0.4-4.0 mU/L) and a low serum free thyroxine (T4) level of 0.8 ng/dL (normal range: 0.9-1.7 ng/dL), consistent with primary hypothyroidism. Her complete blood count revealed a normocytic-normochromic anemia with a hemoglobin level of 11.5 g/dL.

**Hospital Course:**

* On March 11, 2023, Jane was started on levothyroxine therapy at a dose of 100 mcg orally once a day, as per the hospital's endocrinology protocol.
* On March 15, 2023, her TSH level decreased to 12.4 mU/L, and her free T4 level increased to 1.2 ng/dL, indicating a response to therapy.
* On March 18, 2023, Jane's anemia improved, with a hemoglobin level of 12.2 g/dL.
* On March 22, 2023, her serum cholesterol level decreased to 180 mg/dL from an initial value of 220 mg/dL.

**Medications:**

* Levothyroxine: 100 mcg orally once a day, adjusted every 6 weeks as needed.

**Discharge Instructions:**

* Continue taking levothyroxine 100 mcg orally once a day as directed.
* Monitor for signs of hypothyroidism, such as fatigue, weight gain, or cold intolerance.
* Schedule follow-up appointment with the endocrinologist in 6 weeks to reassess TSH and free T4 levels.
* Discuss the importance of adherence to medication therapy and potential interactions with other medications.

**Special Instructions:**

* In the event of a missed dose, take the medication as soon as possible and resume the regular dosing schedule.
* Do not stop taking the medication without consulting the endocrinologist.

**Contact Information:**

* Primary care physician: Dr. John Smith, MD
* Endocrinologist: Dr. Jane Johnson, MD
* Hospital phone number: 555-555-5555

**Additional Notes:**

* Jane Doe was educated on the importance of regular monitoring of her TSH and free T4 levels to ensure optimal thyroid hormone replacement therapy.
* She was advised to report any changes in her symptoms or medication side effects to her healthcare provider.

This discharge summary provides a detailed account of Jane Doe's hospital stay, including her diagnosis of primary hypothyroidism, treatment with levothyroxine, and improvements in her anemia and serum cholesterol levels. The summary also outlines her discharge instructions, special instructions, and contact information for future follow-up appointments.